Skip to content

Lidocaine injection combined with manual therapy in Frozen shoulder.

Efficacy of MRI and clinical findings of Lidocaine injection combined with manual therapy in Frozen shoulder - A prospective, randomized, double - blinded, placebo controlled trial.

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024853
Enrollment
60
Registered
2020-04-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M255- Pain in joint

Interventions

Intervention1: Lidocaine injection and Manual therapy: Manual therapy and exercise, usually delivered together as components of a physical therapy intervention, are commonly used interventions for adh

Sponsors

Prince Sattam Bin Abdulaziz University Al Kharj Saudi Arabia
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age between 18 â?? 60 years with pain over shoulder, restriction in ROM ( >50% loss of ROM in at least three directions, i.e. external rotation, abduction, internal rotation and flexion) for a duration of at least 2 months), unilateral shoulder pain with pain intensity in VAS scale between 4 and 8 mm and willing to participate for the treatment and further follow up program will be included.

Exclusion criteria

Exclusion criteria: Participants with prior injection therapy, bilateral shoulder involvement, associated neck or arm pain, severe musculoskeletal, neural, somatic and psychiatric conditions, waiting for surgery, having alcohol or drug abuse, involving in other weight training programs, participants with other soft tissue injuries, fracture at the limbs, deformities were excluded from the study.

Design outcomes

Primary

MeasureTime frame
1. MRI analysis: (Coracohumeral ligament thickening, fat obliteration of the rotator Interval, rotator interval enhancement, axillary joint capsule enhancement, inferior glenohumeral ligament (IGHL) hyperintensity, inferior glenohumeral ligament thickening) 2. Pain intensity â?? VAS 3. Functional disability â?? Shoulder pain and disability index Timepoint: Baseline, after 4 weeks, 8 weeks and 6 months

Secondary

MeasureTime frame
1. Kinesiophobia â?? Tampa scale 2. Depression â?? Hospital anxiety and depression scale 3. Quality of life â?? SF -36 Timepoint: Baseline, after 4 weeks, 8 weeks and 6 months

Countries

Saudi Arabia

Contacts

Public ContactGopal Nambi

Prince Sattam Bin Abdulaziz University,

physio_gopal@rediffmail.com0501878382

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026